Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic

Published:2017-06-07 Issue:8 Volume:20 Page:799-812
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Cristino Joaquim¹,Finek Jíndřich²,Jandova Petra³,Kolek Martin⁴,Pásztor Bálint⁴,Giannopoulou Christina¹,Qian Yi⁵,Brezina Tomas³,Lothgren Mickael¹

Affiliation:

1. Amgen (Europe) GmbH, Zug, Switzerland;

2. Pilsen Faculty Hospital, Clinic of Oncology and Radiotherapy (FN v Plzni), Pilsen, Czech Republic;

3. Amgen s.r.o., Prague, Czech Republic;

4. Oaks Consulting, Prague, Czech Republic;

5. Amgen Inc., Thousand Oaks, CA, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2017.1328423

Reference52 articles.

1. Metastatic bone disease: clinical features, pathophysiology and treatment strategies

2. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

3. Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases

4. Short-term disability in solid tumor patients with bone metastases and skeletal-related events

5. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India;JCO Global Oncology;2024-03

2. Evaluación económica de denosumab en pacientes con tumores sólidos con metástasis óseas en el IMSS;Gaceta Mexicana de Oncolog�a;2023-06-30

3. A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting;PharmacoEconomics - Open;2022-08-23

4. Evaluation of denosumab in adult oncology patients for the prevention of skeletal related events across a large academic health system;Journal of Oncology Pharmacy Practice;2021-11-05

5. A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer;Expert Opinion on Pharmacotherapy;2021-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3